|
HS Code |
363178 |
As an accredited 6-Bromo-4-Chlorothieno[3,2-D]Pyrimidine factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | |
| Shipping | |
| Storage |
Competitive 6-Bromo-4-Chlorothieno[3,2-D]Pyrimidine prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: admin@sinochem-nanjing.com
Flexible payment, competitive price, premium service - Inquire now!
I see a lot of fine chemicals drift through the industry every year, but 6-Bromo-4-Chlorothieno[3,2-D]Pyrimidine stands out for reasons that go well beyond its mouthful of a name. For chemists focused on pharmaceutical research, it shows up as an essential link in the puzzle—one of those small molecules that quietly shapes the background of much larger discoveries. Speaking from experience, finding a reliable core for novel compound development means time saved, fewer hitches, and more breathing room for creative science.
This compound brings together a thieno[3,2-D]pyrimidine core with bromine and chlorine substitutions. That may sound technical—chemistry often gets tangled up in details—but the important thing here is its versatility. The molecular formula, C6H2BrClN2S, gives you a heavy hitter for synthetic applications, with each atom playing a distinct role when you’re mapping out new routes in medicinal chemistry. Bromine and chlorine, sitting at strategic points on the ring, provide ideal launching pads for further chemical transformation. Reactivity at these sites often makes or breaks an experimental plan.
Looking at this compound in the lab, you notice it has good stability for storage, yet enough reactivity for efficient coupling reactions. The pale solid powder always makes for easy handling—none of that sticky, clumpy unpredictability that comes with some analogs. This sounds like a detail, but efficient workflow often hangs on such practical concerns.
I’ve worked with a few analogs in the thienopyrimidine family, but this one’s halogen pattern gives it unique leveraging points. Some pyrimidines need extra steps to introduce bromine or chlorine, which can be expensive and time-consuming. Here, these groups are already locked in, pre-positioned for cross-coupling work or nucleophilic substitutions. This translates to fewer purification headaches and cleaner product streams—anyone who’s fought through a long filtration knows that’s a welcome change.
Other similar heterocycles either lack the same reactivity at C-6 and C-4, or they introduce steric hindrance that slows down later steps. This thieno[3,2-D]pyrimidine strikes a balance, with enough electronic activation to promote reactions without making the intermediates unstable. That’s not a small detail; consistency across batches keeps a synthetic chemist’s stress in check, especially when scaling up from milligrams to grams or moving toward pilot plant batches.
Most labs that stock 6-Bromo-4-Chlorothieno[3,2-D]Pyrimidine are either dabbling in lead discovery or running structure-activity relationship studies. Many kinase inhibitors trace their roots to thienopyrimidine cores, and academic groups probing new antivirals also put this compound to work. It slots neatly into Suzuki or Buchwald-Hartwig couplings. I remember one project, struggling with a tricky arylation, where alternate routes left me with stubborn side-products. This molecule’s clean reactivity rescued the project, giving solid yields without the need for endless tweaks.
Medicinal chemists value options for scaffold modifications because leads must adapt to every obstacle—solubility, permeability, even patent landscaping. Having ready access to bromo and chloro handles opens the door to all sorts of diversification. Small startups, big pharma, and academic labs all use this as a plugin for fast analog generation, aiming to tweak side chains or fine-tune properties via smart substitutions.
Beyond theory, practical aspects matter. The compound arrives as a free-flowing powder with a decent shelf life, as long as it’s kept dry and in a tightly sealed container. It won’t degrade in transit and doesn’t pose handling hazards out of the ordinary for organohalides. No one wants to spend half a day wrestling with degradation issues or unexplained impurities—labs have enough to juggle already.
In reaction setups, it dissolves in basic organic solvents like DMSO, DMF, or acetonitrile. It tolerates mild heating; glassware doesn’t end up crusted over, and post-reaction workups don’t require multiple scrubbing steps. Such compatibility pays off, especially in busy multi-user labs where equipment turnover is tight.
Plenty of halogenated pyrimidines exist, but not all carry the same combination of reactivity and ease of use. Many close cousins either lack a bromine or a chlorine group, or they distribute halogens at less convenient positions. For example, straight pyrimidines without the thieno ring behave differently in cross-coupling chemistry; they often demand harsher conditions or give less reproducible outcomes.
Thienopyrimidines, on the other hand, insert a sulfur atom into the ring system, which can modulate electronic effects, making downstream reactions more predictable. In head-to-head comparisons, 6-Bromo-4-Chlorothieno[3,2-D]Pyrimidine tends to outperform because of its delicate balance between reactivity (enough to move quickly) and selectivity (avoiding messy side paths). It has a track record in both small batch innovation and larger manufacturing, so scaling doesn’t bring unpleasant surprises.
Drug discovery teams love a reliable building block. The pharmaceutical world doesn’t just chase new chemical entities; it’s always seeking scaffolds that can power series expansion. With the 6-bromo and 4-chloro groups on this core, the options for downstream modifications are wide. These handles let researchers append various side chains or switch out fragments, exploring how small changes might affect biological targets. A molecule that encourages exploration and doesn’t slow down a project with extra steps will always win loyalty in a busy R&D pipeline.
Think back to the way kinase inhibitors and anti-infective drugs depend on interesting heterocycles to make progress. Research has highlighted thienopyrimidines as a privileged scaffold in several active trials. In my experience, walking a molecule from hit to lead without constant rerouting is rare—products like this one cut out detours. They come off the shelf ready for action, often surviving harsh reaction conditions and helping researchers break through to the next promising candidate molecule.
Reproducibility has moved to the front of every chemistry conversation, for good reasons. Sourcing chemicals of consistent quality and well-documented origin now gets more attention than ever, both in academia and the corporate world. Too often, subtle inconsistencies between lots can wreck a promising route. 6-Bromo-4-Chlorothieno[3,2-D]Pyrimidine maintains reliable physical properties, clean spectra, and often exceeds set purity thresholds.
My lab has run multiple parallel syntheses, and this compound rarely introduced any out-of-spec problems. Chromatograms line up batch after batch, and melting point measurements hardly waver. These confirmations cut stress down and allow young chemists to focus on creativity—not troubleshooting. The impact is real: time saved from detective work goes straight back into pushing projects forward.
Chemical safety remains a given in all professional settings, and compounds like this one don’t raise exceptional red flags. Standard precautions—using gloves, eye protection, hooded workspace—cover all the necessary ground. Reliable suppliers will back up each batch with safety and analytical data, and the lack of surprise side products helps keep risks low. Nobody enjoys dealing with hazardous waste or mystery recrystallization problems, and this compound fits comfortably within ordinary lab management frameworks.
Waste handling protocols for halogenated aromatics have improved a lot in recent years, and the absence of additional toxic byproducts eases environmental pressures. Many universities and pharmaceutical companies now run green chemistry reviews before adopting a new synthetic route, and the straightforward nature of this compound earns it a passing grade time and again.
One thing I see among my colleagues—the push to chase new targets and create diverse libraries. 6-Bromo-4-Chlorothieno[3,2-D]Pyrimidine helps avoid bottlenecks, keeping momentum in the lab. It doesn’t force chemists into corners or foster dependence on convoluted protection-deprotection steps. The straightforward reactivity keeps timelines tight, a major asset in competitive fields where speed counts for as much as technical insight.
I’ve seen teams use this scaffold to branch into exploration of enzyme inhibitors and receptor modulators. Once you unlock the chemistry for a new target, questions shift from “Can we make this?” to “Does this work in biology?”—and that brings research closer to the central challenge of drug discovery. No single building block can guarantee medicinal breakthroughs, but reliable stepping stones like this one give every project a running start.
Supply chain resilience and product quality are priorities that have come into focus after disruptions in recent years. Chemists no longer have the luxury of assuming that what’s in the bottle matches what it says on the label, especially after high-profile recalls and supply interruptions. In the case of this compound, large-scale vendors support rigorous quality checks: NMR, HPLC, mass spectrometry, and elemental analysis. Good suppliers keep data on file and actively address batch-to-batch consistency.
In one instance, sudden shortages forced my team to evaluate alternate sources. By comparing multiple samples—even sending out for independent, third-party analyses—we could confirm that this compound’s specification matched expectations. This level of transparency brings trust back to the lab, and allows procurement officers and bench chemists alike to keep confidence in their workflow. If you’re building new pharmaceuticals or just chasing a tough research challenge, the last thing you want to worry about is ingredient reliability.
Green chemistry initiatives continue to shape the way researchers think about small molecule synthesis. While halogenated aromatics historically drew scrutiny, newer manufacturing techniques limit waste and enhance atom economy. Suppliers increasingly publish green metrics and support recycling of spent materials, nudging the field toward cleaner, safer lab environments.
For those working in early discovery or academic research, cost and accessibility also come into play. 6-Bromo-4-Chlorothieno[3,2-D]Pyrimidine often falls within the affordable range for project budgets. Bulk pricing and robust availability mean even modestly funded labs can reliably add it to their toolkit.
Innovation rarely stays still. Inside industry panels or academic conferences, discussion often turns to new frontiers—expanding chemical libraries, accelerating synthesis, or integrating computational design with real-world molecules. With its dual-halogen motif and heterocyclic backbone, this compound keeps earning a place in conversations around fragment-based drug discovery and targeted library construction.
Emerging areas in agrochemicals, specialty materials, and diagnostics have started to pull from pharmaceutical playbooks, looking for scaffolds that bridge properties between biological activity and manufacturability. The versatility of this thienopyrimidine lets it contribute to those fields in ways still unfolding, expanding its relevance beyond the pharma world.
In my own projects and those I’ve followed in industry circles, the most valued tools are those that limit complications and open doors. 6-Bromo-4-Chlorothieno[3,2-D]Pyrimidine is one of those tools—solid, unpretentious, positioned at the heart of forward-thinking research. The industry keeps moving at breakneck speed, and those working at the interface of chemistry and biology depend on materials with a proven track record and room for new ideas.
This compound may never get its name on a commercial drug label. It will, though, form part of the story behind new breakthroughs and quieter advances. In the everyday push to innovate, molecules with reliability and flexibility never go out of fashion.
I’ve watched more than one ambitious project stall out due to unpredictable chemistry or underwhelming raw materials. The lesson from those experiences? Every hour spent wrestling with recalcitrant intermediates steals from the excitement of real discovery. A building block that just works—one that opens up options and isn’t fussy—can make all the difference for a research group on a deadline.
Plenty of options vie for attention in catalogs and price lists, yet refined experience counts more than specs on a sheet. This compound, with its clear chemical logic and direct application, lands near the top of my list for versatile, dependable heterocyclic cores.
Every year, research demands climb—both in terms of pace and complexity. I keep coming back to the value of building blocks that do more than just perform: they build confidence, connect ideas, and support progress. 6-Bromo-4-Chlorothieno[3,2-D]Pyrimidine does that job quietly, fitting into reaction schemes without fanfare and holding up under scrutiny. In a time when attention and lab resources are both stretched, picking reliable partners for every synthesis run pays dividends nobody wants to overlook. This molecule has earned its keep on my shelf, and its role in ongoing discovery efforts just keeps growing.